<DOC>
	<DOCNO>NCT02541721</DOCNO>
	<brief_summary>The current study aim investigate effectiveness clinical symptomatic control tolerability LabiaStick # 01 woman symptomatic non-hypertrophic chronic vulvar dermatosis .</brief_summary>
	<brief_title>Effectiveness Tolerability LabiaStick # 01 Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses</brief_title>
	<detailed_description>Vulvar dermatoses skin disorder affect vulva , cause pruritus , irritation pain . Although prevalence disorder unknown , well accept vulvar symptom common problem woman . LabiaStick # 01 emollient agent whose main function increase skin hydration , provide physical protection decrease symptom possibility recurrence vulvar dermatosis . The medical device apply daily , even , intimal hygiene care . The primary objective study evaluate effectiveness LabiaStick # 01 relief pruritus cause symptomatic non-hypertrophic chronic vulvar dermatosis .</detailed_description>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<criteria>Able willing give write informed consent . Woman , 18 year . Diagnosed symptomatic nonhypertrophic chronic vulvar dermatosis . A pruritus score least 20 100mm VASPR . Willing able comply study requirement . Participant childbearing potential agrees remain abstinent use acceptable contraceptive measure entire duration study . Participant childbearing potential ( e.g. , sexually active , whose current partner reproductive potential ) . Received systemic immunosuppressant therapy ( e.g . systemic corticosteroid ) within 4 week prior admission . Treated daily topical therapy ( e.g . topical corticosteroid , pimecrolimus , tacrolimus ) target vulvar area within 2 week prior admission , opinion investigator might compromise study result . Immunocompromised ( e.g. , lymphoma , AIDS , WiskottAldrich Syndrome ) uncontrolled malignant disease . Suffers systemic generalize infection ( bacterial , viral fungal ) . Diagnosis psoriasis , candidiasis , vulvar intraepithelial neoplasia carcinoma vulva . Pregnancy breastfeed . Documented consistent history hypersensitivity reaction similar topical product . Any condition opinion investigator might prevent subject complete study interfere interpretation study result .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>